Cannabis Landscape
Undergoing Seismic Transition…
Cannabis is expanding
More people using cannabis
- More than 4 in 10 (41%) first used CBD in the previous six months, and about 7 in 10 (68%) began consuming it less than a year previously(1)
U.S. laws have changed
- Hemp is legal at federal level; 4 cannabinoid drugs have received federal approval; 33 states have legalized cannabis for medical purposes; 11 states have legalized cannabis for recreational purposes
Public sector supports it
- 2/3rd of US support legalization; only 1/10th of US oppose legalization for medical or recreational uses
Operational excellence matters
State by state cannabis industry framework ripe for advisory services
- Legal states have unique requirements
- Most states have yet to create social consumption models
- No national standards create vital need to execute locally and optimize cross-state, where possible
Limited tax deductions and access to traditional banking a challenge
- Limited uses of checking / savings accounts; credit cards
- High federal taxes
Consolidation inevitable
Highly fragmented
- A trillion-dollar market in 8 years and currently not a single company in the space generates close to $500 million in revenue
Black market still needs to transition
- Black market has an existing and massive consumer and patient base that has not yet transitioned to the regulated market
Strong Deal Flow (2018)
- +1,000 VC firm invested +$100 billion
- +125 active unique VC investors in Cannabis
Green C Advisors
Well-Positioned For Success
Cannabis is expanding
Hypergrowth market requiring substantial capital and operational scaling is Green C Advisors’ expertise
Operational excellence matters
Able to provide solutions and navigate complex state by state regulatory landscape and unlock cross-state efficiency gains
Consolidation inevitable
Green C Advisors well-positioned to create and capture value
Target Markets in
Cannabis Industry
Medical/OTC Drug Market
Medical/OTC
Drug Market
Farming Cultivation & Dispensaries
Farming Cultivation &
Dispensaries
Extraction & Nutraceuticals
Extraction &
Nutraceuticals
Agtech/Industrials
Agtech/Industrials
Supply Chain
Supply Chain
Recreational Use-CBD/CPG
Recreational
Use-CBD/CPG
OUR TEAM
Our team provides a diverse financial and transactional expertise across a broad range of industries, including all Cannabis sectors and the Health and Consumer industries impacted by Cannabis.
75
YEARS
of
combined investment management experience
35
YEARS
of
small business startups
30
YEARS
of
advisory expertise across various industries
EXECUTIVE TEAM
Curtis Lee Nabors III
Chief Executive Officer, Founder
- Focuses on Cannabis Investment Banking, M&A and business development
- Adaptable, creative and persuasive leader with a 25 year record of delivering results to early mid stage & growth companies
- BA Lynchburg College
Stephen Horowitz
President, Founder
- Primary focus: business development & M&A deals
- Partner of 90M Roll Up and previous COO with 20+ years experience
- BA Lynchburg College
David Hendren
Chief Legal Officer
- Experienced venture capital investor, entrepreneur, board member, executive, and business advisor focused on creating value by developing and commercializing innovations in healthcare, medical, life science, IT, and other market and technology areas
- AB Government Dartmouth College JD Northwestern Law
Michele Castellon
Managing Director
- Corporate Brand Development/Marketing/Sales/Account Management
- Medical CBD experience, 10 + years packaging in music industry and pharmaceutical
- BS Central Connecticut
Tad Huffard
Head of Business Development
- Tad has multiple years of experience managing and operating indoor cultivation facilities. Originally based in northern California, Tad operated over 10,000 ft sq of indoor canopy before being hired as Assistant Head Grower at Green Thumb Industries’ 35,000 ft sq cultivation site in New Jersey.
David Vogel
SVP Advisory
- For two decades, David Vogel has successfully managed and improved the financial organizations of global businesses in the many industries including cannabis
- David has worked in “Big-4”, IBM and other global financial services firms as well as served as CFO and Senior VP of Finance for small and medium sized businesses
BOARD OF DIRECTORS
Curtis Lee Nabors III
Chairman
- Focuses on Cannabis Investment Banking, M&A and business development
Stephen Horowitz
Director
- Primary focus: business development & M&A deals
- Partner of 90M Roll Up and previous COO with 20+ years experience
- BA Lynchburg College
David Hendren
Director
- Experienced venture capital investor, entrepreneur, board member, executive, and business advisor
Jason Quinn
Director
- Leader in regulated mobile gaming, raised over $1.5 billion of private and public capital for DraftKings and led the financial due diligence for the FanDuel/DraftKings merger
Cornelius O’Leary
Director
- Former Connecticut State Senator who served for 20yrs
- He served as both the Minority and Majority Leader of the Senate
Will West
Director
- Will West has a career history as a serial entrepreneur, and a globally-experienced executive with a consistent focus on growth strategies across industries.
- As the Co-Founder and President of Tesseract Medical Research, a California-based life sciences company, Will has vaulted this emerging brand into a distinctive leadership role among a very crowded field.
Joseph J. Spalluto
Director
- Joseph J. Spalluto is a former Group Head, Fixed Income, for Keefe, Bruyette & Woods, an investment bank specializing in the financial services sector.
- He is an accomplished business leader with over 30 years of sales, management, strategic and operational experience in the investment banking industry.
ADVISORY BOARD
Robert Lyons
Advisor
- Mr. Lyons has worked in the financial services industry for over 25 years. After receiving his MBA from University of Chicago in 1987, he went to Merrill Lynch where he worked on the Debt Capital Markets desk
- During his 22 year career at Merrill Lynch he held a variety of debt origination positions, including Global Head of Debt Capital Markets from 2001 through 2005. His final position at Merrill was Vice Chairman in Investment Banking
Bill Dreher
Advisor
- Most recently Bill was CFO of Eco-Gen Laboratories a vertically integrated grower of industrial hemp
- At Eco-Gen Bill led all financial operations including raising $40m
- Prior to Eco-Gen Bill worked for several bulge bracket financial services institutions with a focus on financial analysis and consumer strategy in the retail and luxury goods industries
- Bill led Deutsche Banks US Equity Research team covering the retail sector for over eight years
MARKET DATA
GLOBAL MOVEMENT
TOWARD REGULATION
More than 50 countries worldwide have legalized some form of cannabis for medical use, and six – Canada, Uruguay, South Africa, Guam, Georgia and the Northern Mariana Islands have legalized cannabis for personal or recreational use.
U.S. CANNABIS MARKET WILL BE
THE LARGEST GLOBALLY
• U.S. cannabis market estimated to be over $68 Billion when legalized.
• Cannabis global economic impact estimated to be one trillion+ US dollars.
WEED LEGAL IN MOST OF AMERICA
GREEN C ADVISORS
CLIENT MOMENTUM
NOTHING IN THIS WEBSITE IS INTENDED TO CONSTITUTE AN OFFER OF SOLICITATION TO SELL OR A SOLICITATION OF AN OFFER TO BUY A SECURITY OR ANY INVESTMENT INTEREST IN ANY VEHICLE The information contained herein is deemed to be from reliable sources however, Green C Advisors Inc does not warrant its completeness or accuracy In addition, the information and the views contained herein are subject to change at any time at the sole and absolute discretion of Green C Advisors The investment performance discussed in this presentation does not necessarily represent the investments’ performance and should not be used to predict the investments’ returns The investments’ performance may be volatile, and investors may lose all or a substantial portion of their investment If included, index information is intended merely to show the general trend in the markets for the periods indicated and is not intended to imply that the investments are similar to the indices either in composition or risk Any reference to a specific security in this presentation does not imply that Green C Advisors had or will have a long or short position in that security Such securities are shown for illustrative purposes only and their mention here is not an endorsement of such securities An investment in any strategy managed by Green C Advisors has not been recommended or approved by any U S Federal or state securities commission or regulatory authority or those of the Cayman Islands Furthermore, the foregoing authorities have not passed upon the accuracy or determined the adequacy of this document Any representation to the contrary is a criminal offense Certain statements made during this presentation are forward looking and are subject to risks and uncertainties The forward looking statements made are based on our beliefs, assumptions and expectations of future performance, taking into account information currently available to us Actual results could differ materially from the forward looking statements made in this presentation When we use the words “ believe,”“ expect,”“ anticipate,”“ plan,”“ will,”“ or other similar expressions, we are identifying forward looking statements The forward looking statements made in this presentation are subject to the safe harbor of the private securities litigation reform act of 1995.